Development and validation of a biomonitoring method to measure As, Cr, and Ni in human urine samples by ICP-UCT-MS

Development and validation of a biomonitoring method to measure As, Cr, and Ni in human urine samples by ICP-UCT-MS
We developed an inductively coupled plasma mass spectrometry (ICP-MS) method utilizing Universal Cell Technology (UCT) with a PerkinElmer NexION ICP-MS, to measure arsenic (As), chromium (Cr), and nickel (Ni) in human urine samples. The developments of the UCT allowed us to increase the calibration vary to make the method relevant for each low concentrations of biomonitoring purposes and excessive concentrations which may be noticed from acute exposures and emergency response.
Our method analyzes As and Ni in kinetic vitality discrimination (KED) mode with helium (He) gasoline, and Cr in dynamic response cell (DRC) mode with ammonia (NH3) gasoline. The mixture of these components is difficult as a result of a carbon supply, ethanol (EtOH), is required for normalization of As ionization in urine samples, which creates a spectral overlap (40Ar12C+) on 52Cr. This method moreover improved lab effectivity by combining components from two of our beforehand printed strategies(Jarrett et al., 2007; Quarles et al., 2014) permitting us to measure Cr and Ni concentrations in urine samples collected as half of the National Health and Nutrition Examination Survey (NHANES) starting with the 2017-2018 survey cycle.
We current our rigorous validation of the method selectivity and accuracy utilizing National Institute of Standards and Technology (NIST) Standard Reference Materials (SRM), precision utilizing in-house ready high quality management supplies, and a dialogue of the use of a modified UCT, a BioUCell, to deal with an ion transmission phenomenon we noticed on the NexION 300 platform when utilizing increased elemental concentrations and excessive cell gasoline pressures. Specimens had been collected at 130,012 (64.4%) hospitalizations with any antibiotic use, and a minimum of one bacterial organism was remoted at 35.1% of these stays. Frequency of bacterial isolation assorted extensively by analysis class and antibiotic group. Under more and more lenient standards, 10.2% to 31.4% of 974,733 antibiotic days-of-therapy may very well be linked to a potential bacterial pathogen.

Rational choice of a biomarker panel focusing on unmet scientific wants in viral kidney damage

The pipeline of biomarker translation from bench to bedside is difficult and restricted biomarkers have been adopted to routine scientific care. Ideally, biomarker analysis and improvement ought to be pushed by unmet scientific wants in well being care. To information researchers, scientific chemists and clinicians in their biomarker analysis, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) has developed a structured questionnaire in which the scientific gaps in present scientific pathways are recognized and fascinating efficiency specs are predefined. In kidney damage, the excessive prevalence of the syndrome acute kidney damage (AKI) in the hospital setting has a important influence on morbidity, affected person survival and well being care prices, however the use of biomarkers indicating early kidney damage in day by day affected person care stays restricted.

Routinely, medical labs measure serum creatinine, which is a purposeful biomarker, insensitive for detecting early kidney harm and can not distinguish between renal and prerenal AKI. The perceived unmet scientific wants in kidney damage had been recognized via the EFLM questionnaire. Nephrologists inside our tertiary care hospital emphasised that biomarkers are wanted for (1) early analysis of in-hospital AKI after a medical insult and in critically in poor health sufferers, (2) danger stratification for kidney damage prior to a scheduled (elective) intervention, (3) kidney damage monitoring in sufferers scheduled to obtain nephrotoxic medicine and after kidney transplantation and (4) differentiation between prerenal AKI and structural kidney harm.

The biomarker search and choice technique resulted in a rational choice of an eleven-protein urinary panel for kidney damage that concentrate on these scientific wants. To assess the scientific utility of the proposed biomarker panel in kidney damage, a multiplexed LC-MS check is now in improvement for the meant translational analysis. The rugged method detection limits, calculated from measurements in greater than 60 runs, for As, Cr, and Ni are 0.23 μg L-1, 0.19 μg L-1, and 0.31 μg L-1, respectively.

Development and validation of a biomonitoring method to measure As, Cr, and Ni in human urine samples by ICP-UCT-MS

Different approaches to enhance cohort identification utilizing digital well being data: X-linked hypophosphatemia for example

Electronic Health Records (EHRs) symbolize a supply of excessive worth knowledge which is commonly underutilized as a result of exploiting the knowledge contained therein requires specialised strategies unavailable to the tip person i.e. the doctor or the investigator. Here I describe 4 easy and sensible avenues that can permit the usual EHR finish person to establish affected person cohorts: the use of diagnostic codes from completely different worldwide catalogues; a search in studies from complementary assessments (e.g. radiographs or lab assessments) for any consequence of curiosity; a free textual content search; or a drug prescription search in the affected person’s digital prescription document.

This medical method is buying nice significance in the sector of uncommon ailments, and right here I display its utility with X-linked hypophosphatemia. The use of these 4 EHR questioning approaches makes discovering a cohort of sufferers of any situation or illness possible and manageable, and as soon as every case document is checked, a well-defined cohort could be assembled.

Goat IgG-HRP conjugate (isotype control)

20011-HP 100 ug
EUR 164

Goat IgG-PE conjugate (isotype control)

20011-PE 100 tests
EUR 225

Rat IgG-Biotin conjugate (isotype control) (Isotype control)

20005-B 100 ug
EUR 164

Rat IgG-FITC conjugate (isotype control) (Isotype control)

20005-F 100 ug
EUR 164

Rat IgG-HRP conjugate (isotype control) (Isotype control)

20005-HP 100 ug
EUR 164

Rat IgG-PE conjugate (isotype control) (Isotype control)

20005-PE 25 tests
EUR 202

Goat F(ab')2 IgG Isotype Control

abx405076-05mg 0.5 mg
EUR 411
  • Shipped within 1 week.

Goat IgG (fc)-Biotin conjugate (isotype control)

20011-Fc-B 100 ug
EUR 164

Goat IgG (fc)-FITC conjugate (isotype control)

20011-Fc-F 100 ug
EUR 164

Goat IgG (fc)-HRP conjugate (isotype control)

20011-Fc-HP 100 ug
EUR 164

Rabbit IgG Isotype Control

IC001-100ul 100ul
EUR 122

Mouse IgG Isotype Control

IC002-100ul 100ul
EUR 122

Rabbit IgG Isotype Control

abx125003-100ul 100 ul
EUR 203
  • Shipped within 5-10 working days.

IgG Isotype Control antibody

10R-6524 50 ug
EUR 133
Description: Armenian Hamster monoclonal IgG Isotype Control antibody

IgG Isotype Control antibody

10R-6525 50 ug
EUR 133
Description: Syrian Hamster monoclonal IgG Isotype Control antibody

Rat IgG Isotype Control

31-AR15 10 mg
EUR 220
Description: Purified Rat IgG Isotype Control

Goat IgG (-ve control for flow cytometry) (isotype control)

20011-100 100 test
EUR 103

Goat F(ab')2 IgG Isotype Control (FITC)

abx405077-100tests 100 tests
EUR 495
  • Shipped within 1 week.

Goat F(ab')2 IgG Isotype Control (RPE)

abx405078-05ml 0.5 ml
EUR 537
  • Shipped within 1 week.

Goat IgG, purified (serum non-immune, isotype control)

20011-1 1 mg
EUR 141

Goat IgG, purified (serum non-immune, isotype control)

20011-25 25 mg
EUR 469

Goat IgG, purified (serum non-immune, isotype control)

20011-5 5 mg
EUR 286

Armenian Hamster IgG Isotype control

AIGGA-100 100 µg
EUR 574.16

Armenian Hamster IgG Isotype control

AIGGA-25 25 µg
EUR 282.96

Armenian Hamster IgG Isotype control

AIGGB-200 200 µg
EUR 472.24

Armenian Hamster IgG Isotype control

AIGGB-50 50 µg
EUR 239.28

Armenian Hamster IgG Isotype control

AIGGF-200 200 µg
EUR 545.04

Armenian Hamster IgG Isotype control

AIGGF-50 50 µg
EUR 268.4

Armenian Hamster IgG Isotype control

AIGGPE-100 100 µg
EUR 515.92

Armenian Hamster IgG Isotype control

AIGGPE-25 25 µg
EUR 253.84

Armenian Hamster IgG Isotype control

AIGGPP-100 100 µg
EUR 574.16

Armenian Hamster IgG Isotype control

AIGGPP-25 25 µg
EUR 268.4

Armenian Hamster IgG Isotype control

AIGGPP5.5-100 100 µg
EUR 646.96

Armenian Hamster IgG Isotype control

AIGGPP5.5-25 25 µg
EUR 282.96

Armenian Hamster IgG Isotype control

AIGGPU-50 50 µg
EUR 195.6

Armenian Hamster IgG Isotype control

AIGGPU-500 500 µg
EUR 428.56

Hamster (Armenian) IgG Isotype Control

abx405028-025mg 0.25 mg
EUR 384
  • Shipped within 1 week.

Hamster (Arnenian) IgG Isotype Control

abx405029-05mg 0.5 mg
EUR 592
  • Shipped within 1 week.

Hamster (Syrian) IgG Isotype Control

abx405032-025mg 0.25 mg
EUR 384
  • Shipped within 1 week.

Rat IgG purified (isotype control)

20005-1-200 0.5 ml
EUR 103

Rat IgG, purified (Isotype control)

20005-5 5 mg
EUR 286

Sheep IgG, purified (isotype control)

20006-1 1 mg
EUR 141

Rabbit IgG-biotinylated (isotype control)

20009-BT-1 1 mg
EUR 286

IgG Isotype Control antibody (FITC)

61R-1136 50 ug
EUR 165
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (FITC)

IgG Isotype Control antibody (PE)

61R-1337 200 ug
EUR 440
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (PE)

IgG Isotype Control antibody (PE)

61R-1338 50 ug
EUR 181
Description: Syrian Hamster monoclonal IgG Isotype Control antibody (PE)

IgG Isotype Control antibody (biotin)

61R-1586 50 ug
EUR 165
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (biotin)

IgG Isotype Control antibody (biotin)

61R-1587 50 ug
EUR 165
Description: Syrian Hamster monoclonal IgG Isotype Control antibody (biotin)

IgG Isotype Control antibody (allophycocyanin)

61R-1768 100 ug
EUR 349
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (allophycocyanin)

IgG Isotype Control antibody (allophycocyanin)

61R-1769 50 ug
EUR 219
Description: Syrian Hamster monoclonal IgG Isotype Control antibody (allophycocyanin)

IgG Isotype Control antibody (FITC)

61R-1800 25 ug
EUR 205
Description: Rabbit polyclonal IgG Isotype Control antibody (FITC)

FITC Rabbit IgG - Isotype control

DB-1000 100 tests
EUR 422

FITC Rabbit IgG - Isotype control

DB1000 100 tests
EUR 422

Rabbit IgG Isotype control, Concentrate

NG910C 0.5 ml
EUR 392

Syrian Hamster IgG Isotype Control

SIGGA-100 100 µg
EUR 574.16

Syrian Hamster IgG Isotype Control

SIGGB-200 200 µg
EUR 472.24

Syrian Hamster IgG Isotype Control

SIGGF-200 200 µg
EUR 545.04

Syrian Hamster IgG Isotype Control

SIGGPE-100 100 µg
EUR 515.92

Syrian Hamster IgG Isotype Control

SIGGPP5.5-100 100 µg
EUR 676.08

Syrian Hamster IgG Isotype Control

SIGGPP5.5-25 25 µg
EUR 355.76

Syrian Hamster IgG Isotype Control

SIGGPU-500 500 µg
EUR 428.56

Donkey IgG (Control, non-immune, isotype control)

20028-1 1 mg
EUR 164

Goat IgG Control

GT15900 1 mg
EUR 166

Goat IgG control

31R-AG001 1 mg
EUR 127
Description: Goat Immunoglobulins Goat IgG control

Rabbit IgG Isotype Control APC Conjugate

APCCON 0.15 mg
EUR 261

Rabbit IgG Isotype Control FITC Conjugate

FITCCON 0.15 mg
EUR 261

Hamster (Arnenian) IgG Isotype Control (FITC)

abx405030-01mg 0.1 mg
EUR 384
  • Shipped within 1 week.

Hamster (Arnenian) IgG Isotype Control (RPE)

abx405031-01mg 0.1 mg
EUR 509
  • Shipped within 1 week.

Hamster (Syrian) IgG Isotype Control (FITC)

abx405033-01mg 0.1 mg
EUR 398
  • Shipped within 1 week.

Hamster IgG, purified (Syrian, isotype control)

20003-1 1 mg
EUR 141

Hamster IgG, purified (Armenian, Isotype control)

20003-1AH 1 mg
EUR 263

Human IgG-HRP Conjugate (isotype control)

20007-1-HP 500 ug
EUR 202

Mouse IgG-Biotin conjugate (isotype control)

20008-B 50 Tests
EUR 164

Mouse IgG-Biotin conjugate (isotype control)

20008-BT-1 1 mg
EUR 164

Mouse IgG-FITC conjugate (isotype control)

20008-F 100 tests
EUR 164

Mouse IgG-HRP conjugate (isotype control)

20008-HP 50 Tests
EUR 164

Mouse IgG-PE conjugate (isotype control)

20008-PE 50 Tests
EUR 164

Rabbit IgG-FITC conjugate (isotype control)

20009-F 100 ug
EUR 164

Rabbit IgG-HRP conjugate (isotype control)

20009-HP 100 ug
EUR 164

Rabbit IgG-PE conjugate (isotype control)

20009-PE 100 tests
EUR 225

Mouse IgG Isotype Control RPE Conjugate

MRPECON 0.15 mg
EUR 261

Rabbit IgG Isotype Control PerCP Conjugate

PERCPCON 0.15 mg
EUR 261

Mouse IgG Isotype Control FITC Conjugate

MFITCCON 0.15 mg
EUR 261

Mouse IgG Isotype Control PerCP Conjugate

MPERCPCON 0.15 mg
EUR 261

Mouse IgG Isotype Control APC Conjugate

MAPCCON 0.15 mg
EUR 261

Rabbit IgG Isotype Control RPE Conjugate

RPECON 0.15 mg
EUR 261

Donkey IgG (non-immune, isotype control) IgG, purified

20015-10 10 mg
EUR 286

Llama IgG (Control, non-immune, isotype control, ELISA grade)

20030-1 1 mg
EUR 164

Camel IgG (Control, non-immune, isotype control, ELISA grade)

20031-1 1 mg
EUR 164

Alpaca IgG (Control, non-immune, isotype control, ELISA grade)

20032-1 1 mg
EUR 164

IgG Isotype Control Fc fusion protein (FITC)

35R-0013 50 ug
EUR 165
Description: Syrian Hamster monoclonal IgG Isotype Control Fc fusion protein (FITC)

Hamster IgG-Biotin conjugate, isotype control (Syrian)

20003-1-B 100 test
EUR 164

Hamster IgG-Cy5 conjugate, isotype control (Syrian)

20003-1-Cy5 50 tests
EUR 225

Hamster IgG-FITC conjugate, isotype control (Syrian)

20003-1-F 100 tests
EUR 164

Hamster IgG-HRP conjugate, isotype control (Syrian)

20003-1-HP 100 tests
EUR 164

G. Pig IgG-Biotin conjugate (isotype control)

20004-B 100 ug
EUR 202

G. Pig IgG-FITC conjugate (isotype control)

20004-F 100 ug
EUR 202

G. Pig IgG-HRP conjugate (isotype control)

20004-HP 100 ug
EUR 202

Rat IgG Fab fragment, purified (isotype control)

20005-1-FAB 1 mg
EUR 164

Rat IgG (Fc) fragment, purified (isotype control)

20005-1-FC 0.5 mg
EUR 250

Human IgG-Fc fragment purified (isotype control)

20007-F100 100 ug
EUR 141

Human IgG-Fc fragment purified (isotype control)

20007-F1000 1 mg
EUR 347

Mouse IgG Fab-Biotin conjugate (isotype control)

20008-Fab-B 100 ug
EUR 164

Mouse IgG Fab-FITC conjugate (isotype control)

20008-Fab-F 100 ug
EUR 164

Mouse IgG Fab-HRP conjugate (isotype control)

20008-Fab-HP 100 ug
EUR 164

Chimpanzee IgG (non-immune, isotype control), purified

20012-Ch-1 1 mg
EUR 225

Donkey IgG (non-immune, isotype control), purified

20015-1 1 mg
EUR 141

Dog IgG (isotype control, non-immune), purified

20016-1 1 mg
EUR 141

Baboon IgG (non-immune, isotype control), purified

20118-1 1 mg
EUR 202

Baboon IgG (non-immune, isotype control), purified

20118-10 10 mg
EUR 895

Bat IgG (non-immune, isotype control), purified

20121-1 25 ug
EUR 286

Mouse IgG Isotype control; Ready-To-Use

NG903 7 ml
EUR 241

Goat IgG Control Sera

20011-250 0.5 ml
EUR 103

Rabbit Isotype Control

IMN-001 100 µg
EUR 199.5

Rabbit Isotype Control

abx200646-100ug 100 ug
EUR 328
  • Shipped within 2-3 weeks.

Cat IgG, unlabeled (non-immune, isotype control) purified

20002-1-UL 1 mg
EUR 164

Hamster IgG-R-PE conjugate, isotype control (Syrian)

20003-1-PE 50 tests
EUR 225

Rat IgG, purified (Whole, non-immune) (isotype control)

20005-1 1 mg
EUR 141

Rat IgG (Fc)-Biotin Conjuagte (isotype control), purified

20005-1-FC-B 0.1 mg
EUR 225

Rat IgG (Fc)-FITC Conjuagte (isotype control), purified

20005-1-FC-F 0.1 mg
EUR 225

Rat IgG (Fc)-HRP Conjuagte (isotype control), purified

20005-1-FC-HP 0.1 mg
EUR 225

Rat IgG, purified (Whole, non-immune) (isotype control)

20005-10 10 mg
EUR 408

Human IgG, purified (serum, non-immune, isotype control)

20007-1-1 1 mg
EUR 141

Human IgG, purified (serum, non-immune, isotype control)

20007-1-100 100 mg
EUR 895

Human IgG, purified (serum, non-immune, isotype control)

20007-1-25 25 mg
EUR 651

Human IgG, purified (serum, non-immune, isotype control)

20007-1-5 5 mg
EUR 286

Mouse IgG, purified (serum non-immune, isotype control)

20008-1 1 mg
EUR 141

Mouse IgG, purified (serum non-immune, isotype control)

20008-100 100 mg
EUR 598

Mouse IgG, purified (serum non-immune, isotype control)

20008-5 5 mg
EUR 286

Mouse IgG F(c)-Biotin conjugate (isotype control)

20008-Fc-B 100 ug
EUR 164

Mouse IgG F(c)-FITC conjugate (isotype control)

20008-Fc-F 100 ug
EUR 164

Mouse IgG F(c)-HRP conjugate (isotype control)

20008-Fc-HP 100 ug
EUR 164

Mouse IgG-R-PE-Cy5 conjugate (isotype control)

20008-PC5 50 Tests
EUR 225

Rabbit IgG, purified (serum non-immune, isotype control)

20009-1 1 mg
EUR 141

Rabbit IgG, purified (serum non-immune, isotype control)

20009-25 25 mg
EUR 469

Rabbit IgG, purified (serum non-immune, isotype control)

20009-5 5 mg
EUR 286

Rabbit IgG F(c)-biotin conjugate, isotype control

20009-Fc-B 100 ug
EUR 164

Rabbit IgG F(c)-FITC conjugate, isotype control

20009-Fc-F 100 ug
EUR 164

Rabbit IgG F(c)-HRP conjugate, isotype control

20009-Fc-HP 100 ug
EUR 164

Chicken IgG unlabeled (isotype control, non-immune), purified

20010-1 1 mg
EUR 141

Monkey IgG (Rhesus, non-immune, isotype control), purified

20012-1 1 mg
EUR 202

Squirrel Monkey IgG (non-immune, isotype control), purified

20012-1-SM 100 ug
EUR 164

Monkey IgG (Rhesus, non-immune, isotype control), purified

20012-10 10 mg
EUR 895

Pig IgG (swine non-immune, isotype control), purified

20017-1 1 mg
EUR 141
The Children’s Health Exposure Analysis Resource (CHEAR) program permits researchers to increase their analysis targets by providing the evaluation of environmental exposures in their beforehand collected biospecimens. Samples are analyzed in one of CHEAR’s community of six laboratory hubs with the flexibility to assess a big selection of environmental chemical compounds. The means to assess inter-study variability is essential for researchers who need to mix datasets throughout research and laboratories.

Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach

Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach
To eradicate hepatitis C, Rwanda is conducting nationwide mass screenings and offering to folks with continual hepatitis C free entry to Direct Acting Antivirals (DAAs). Until 2020, prescribers educated and licensed to provoke DAA treatment have been based mostly at district hospitals, and entry to DAAs stays costly and geographically troublesome for rural sufferers. We carried out a mobile clinic to supply DAA treatment initiation at primary-level well being services amongst folks with continual hepatitis C recognized via mass screening campaigns in rural Kirehe and Kayonza districts.
The mobile clinic workforce was composed of one clinician licensed to handle hepatitis, one lab technician, and one driver. Eligible sufferers acquired same-day medical consultations, counselling, laboratory exams and DAA initiation. Using medical databases, registers, and program data, we in contrast the quantity of sufferers who initiated DAA treatment earlier than and in the course of the mobile clinic marketing campaign. We assessed linkage to care in the course of the mobile medical marketing campaign and assessed predictors of linkage to care. We additionally estimated the associated fee per affected person of offering mobile providers and the discount in out-of-pocket prices related to accessing DAA treatment via the mobile clinic moderately than the usual of care.
Prior to the mobile clinic, solely 408 sufferers in Kirehe and Kayonza had been initiated on DAAs over a 25-month interval. Between November 2019 and January 2020, out of 661 eligible sufferers with hepatitis C, 429 (64.9%) have been linked to care via the mobile clinic. Having a phone quantity and full handle recorded at screening have been strongly related to linkage to care. The value per affected person of the mobile clinic program was 29.36 USD, excluding government-provided DAAs.
Providing sufferers with same-day laboratory exams and medical session at primary-level well being services lowered out-of-pocket bills by 9.88 USD. The mobile clinic was a possible technique for offering speedy treatment initiation amongst folks chronically contaminated by hepatitis C, recognized via a mass screening marketing campaign. Compared to the usual of care, mobile clinics reached extra sufferers in a a lot shorter time. This low-cost technique additionally lowered out-of-pocket expenditures amongst sufferers. However, long-term, sustainable care would require decentralization to the first well being-centre stage.

Seasonal Diversity of Lactic Acid Bacteria in Artisanal Yoghurt and Their Antibiotic Susceptibility Pattern

The microbiological high quality of artisanal yoghurt marketed in some areas of Cameroon was evaluated in the course of the dry and wet seasons alongside three industrial manufacturers and the susceptibility of isolates to some typical antibiotics. A complete of ninety-six (96) samples have been collected, and the microbiological high quality was based mostly on the entire depend of lactic acid micro organism (lactobacilli and cocci) in addition to the identification of species current utilizing identification kits. The susceptibility of isolates was decided utilizing the microdilution methodology. The lactobacillus counts of domestically made yoghurts throughout each seasons have been decrease than these of the industrial samples.

However, there was a common discount of viable depend of lactobacilli throughout the samples in the course of the wet season when in comparison with the dry season whereas a common improve in the entire coccus depend was noticed in the course of the wet season besides samples from Bamenda which as a substitute decreased. Five (5) Lactobacillus species belonging to 1 genera have been recognized from 29 lactobacillus isolates. Lactobacillus bulgaricus was the very best (64.28%), current in 71.42%, 50.00%, 33.33%, and 33.33% (dry season) in comparison with 85.71%, 100%, 33.33%, and 25.00% (wet season) from Bamenda, Dschang, Bafoussam, and industrial, respectively. More so, 14 cocci,

Three coccobacilli, and 1 rod species belonging to five, 3, and 1 genera have been recognized, from 74 cocci, 12 coccobacilli, and three rod isolates, respectively, with Streptococcus thermophilus being the very best (35.55%). However, 93.33% of the lactobacillus isolates have been very delicate to the antibiotics used, whereas solely 20% of cocci have been delicate. This outcome means that the paucity of the suitable lactic acid micro organism (LAB) and presence of pathogenic LAB attributable to the absence of high quality management and ignorance may hinder its well being advantages and safety supplied to customers with a resultant publicity to excessive danger of meals borne an infection and intoxication coupled to the resistant strains.

Utilization administration of laboratory testing is a development growing in relevance because the well beingcare panorama continues to evolve towards value-based care, and lots of pediatric and grownup laboratories are growing methods for utilization administration. The Pediatric Laboratory Guidance Service (PLUGS) began an annual convention devoted to the vital subjects and challenges associated to lab utilization. This 12 months, the 2-day PLUGS Summit boasted over 10 hours of persevering with medical training and a number of other networking occasions to convey collectively leaders in the sector of lab utilization. The theme of the 2016 assembly targeted on bringing collectively medical labs, reference labs, and insurance coverage firms to extend the worth of laboratory testing, in the context of the US well being financial system.

Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach

Linking clinotypes to phenotypes and genotypes from laboratory take a look at outcomes in complete bodily exams

In this work, we aimed to reveal find out how to make the most of the lab take a look at outcomes and different medical data to help precision medication analysis and medical selections on complicated illnesses, with the help of digital medical report services. We outlined “clinotypes” as medical data that might be noticed and measured objectively utilizing biomedical devices. From well-known ‘omic’ drawback definitions, we outlined issues utilizing clinotype data, together with stratifying patients-identifying sub cohorts for future research
mining important associations between clinotypes and particular phenotypes-diseases, and discovering potential linkages between clinotype and genomic data. We solved these issues by integrating public omic databases and making use of superior machine studying and visible analytic methods on two-year well being examination data from a giant inhabitants of well beingy southern Chinese people (dimension n = 91,354). When growing the answer, we rigorously addressed the lacking data, imbalance and non-uniformed knowledge annotation points.
Anti-human CD14 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00137-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD14 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD11b Monoclonal Antibody FITC Conjugated, Flow Validated
FC00144-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD11b Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD19 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00154-FITC 25 Tests, 100 Tests, 200 Tests
EUR 102
Description: Mouse Monoclonal human CD19 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD38 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00193-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD38 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD25 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00214-FITC 25 Tests, 100 Tests, 200 Tests
EUR 108
Description: Mouse Monoclonal human CD25 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD4 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00344-FITC 25 Tests, 100 Tests, 200 Tests
EUR 96
Description: Mouse Monoclonal human CD4 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD5 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00480-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD5 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD45 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00555-FITC 25 Tests, 100 Tests, 200 Tests
EUR 114
Description: Mouse Monoclonal human CD45 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD2 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00570-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD2 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD71 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00591-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD71 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD62L Monoclonal Antibody FITC Conjugated, Flow Validated
FC00652-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD62L Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD59 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00914-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD59 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Human CD81 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01281-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal Human CD81 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD117 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01335-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD117 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD16 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01408-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD16 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD32 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01450-FITC 25 Tests, 100 Tests, 200 Tests
EUR 120
Description: Mouse Monoclonal human CD32 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Human CD31 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01513-FITC 25 Tests, 100 Tests, 200 Tests
EUR 130
Description: Mouse Monoclonal Human CD31 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD90 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01818-FITC 25 Tests, 100 Tests, 200 Tests
EUR 153
Description: Mouse Monoclonal human CD90 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD7 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01974-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD7 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD235a Monoclonal Antibody FITC Conjugated, Flow Validated
FC02184-FITC 25ug, 100ug
EUR 140
Description: Mouse Monoclonal human CD235a Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD8 Monoclonal Antibody FITC Conjugated, Flow Validated
FC02236-FITC 25 Tests, 100 Tests, 200 Tests
EUR 96
Description: Mouse Monoclonal human CD8 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD13 Monoclonal Antibody FITC Conjugated, Flow Validated
FC02591-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD13 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD3 Monoclonal Antibody FITC Conjugated, Flow Validated
FC02675-FITC 25 Tests, 100 Tests, 200 Tests
EUR 101
Description: Mouse Monoclonal human CD3 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD20 Monoclonal Antibody FITC Conjugated, Flow Validated
FC03780-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD20 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Human CD161 Monoclonal Antibody FITC Conjugated, Flow Validated
FC03917-FITC 25 tests, 100 tests
EUR 160
Description: Mouse Monoclonal Human CD161 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD10 Monoclonal Antibody FITC Conjugated, Flow Validated
FC04065-FITC 25 Tests, 100 Tests, 200 Tests
EUR 125
Description: Mouse Monoclonal human CD10 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Human CD3 Monoclonal Antibody FITC Conjugated, Flow Validated
FC04405-FITC 25 tests, 100 tests
EUR 96
Description: Mouse Monoclonal Human CD3 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Human CD11a Monoclonal Antibody FITC Conjugated, Flow Validated
FC04466-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal Human CD11a Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD15 Monoclonal Antibody FITC Conjugated, Flow Validated
FC04535-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD15 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Human CD66b Monoclonal Antibody FITC Conjugated, Flow Validated
FC05978-FITC 25 tests, 100 tests
EUR 137
Description: Mouse Monoclonal Human CD66b Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD57 Monoclonal Antibody FITC Conjugated, Flow Validated
FC09548-FITC 25 Tests, 100 Tests, 200 Tests
EUR 140
Description: Mouse Monoclonal human CD57 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human HLA-DR Monoclonal Antibody FITC Conjugated, Flow Validated
FC00568-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human HLA-DR Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD55/Daf Monoclonal Antibody FITC Conjugated, Flow Validated
FC00910-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD55/Daf Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Mouse TCR beta Monoclonal Antibody FITC Conjugated, Flow Validated
FC09166-FITC 25 ug, 100ug, 500ug
EUR 91
Description: Hamster Monoclonal Mouse TCR beta Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Mouse.
Anti-Human HLA-ABC Monoclonal Antibody FITC Conjugated, Flow Validated
FC20056-FITC 25 Tests , 100 Tests , 200 Tests
EUR 137
Description: Mouse Monoclonal Human HLA-ABC Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Human CD54 (ICAM-1) Monoclonal Antibody FITC Conjugated, Flow Validated
FC00171-FITC 25 tests, 100 tests
EUR 149
Description: Mouse Monoclonal Human CD54 (ICAM-1) Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD33/Siglec 3 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01508-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD33/Siglec 3 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-human CD22/Siglec 2 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01572-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal human CD22/Siglec 2 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Human CD14 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00137-FITC-1 25 Tests, 100 Tests, 200 Tests
EUR 95
Description: Mouse Monoclonal Human CD14 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Mouse CD19 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00154-1-FITC 25ug, 100ug, 500ug
EUR 96
Description: Rat Monoclonal Mouse CD19 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Mouse.
Anti-Human CD54 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00171-FITC-1 25 Tests, 100 Tests, 200 Tests
EUR 130
Description: Mouse Monoclonal Human CD54 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Mouse CD4 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00344-3-FITC 25ug, 100ug, 500ug
EUR 85
Description: Rat Monoclonal Mouse CD4 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Mouse.
Anti-Mouse CD45.2 Monoclonal Antibody FITC Conjugated, Flow Validated
FC00555-8-FITC 25ug, 100ug, 500ug
EUR 96
Description: Mouse Monoclonal Mouse CD45.2 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Mouse.
Anti-Human CD45RO Monoclonal Antibody FITC Conjugated, Flow Validated
FC00555-FITC-1 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal Human CD45RO Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Human CD3 Monoclonal Antibody FITC Conjugated, Flow Validated
FC02675-FITC-1 25 Tests, 100 Tests, 200 Tests
EUR 73
Description: Mouse Monoclonal Human CD3 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Anti-Mouse CD3e Monoclonal Antibody FITC Conjugated, Flow Validated
FC04405-3-FITC 25ug, 100ug, 500ug
EUR 79
Description: Hamster Monoclonal Mouse CD3e Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Mouse.
Anti-Human CD3 Monoclonal Antibody FITC Conjugated, Flow Validated
FC04405-4-FITC 25 tests, 100 tests, 500 tests
EUR 96
Description: Mouse Monoclonal Human CD3 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Mouse anti-human CD7 Monoclonal Antibody FITC Conjugated, Flow Validated
FC01974-1-FITC 25 Tests, 100 Tests, 200 Tests
EUR 137
Description: Mouse Monoclonal Mouse human CD7 Antibody FITC Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.
Monoclonal Anti-Rat IgG1-FITC Conjugate
50126-FITC 0.5 ml
EUR 286
Concanavalin A Lectin (ConA)-FITC conjugate
CONA15-FITC 0.5 ml
EUR 286
Aleuria Aurantia Lectin (Aal)-FITC conjugate
AAL15-FITC 0.5 ml
EUR 225
Lens culinaris Lectin (LCA)-FITC conjugate
LCA15-FITC 0.5 ml
EUR 286
Rabbit Anti-Salmonella IgG-FITC conjugate
SLM11-FITC 0.5 ml
EUR 347
Sambucus nigra Lectin (SNA)-FITC conjugate
SNA15-FITC 0.5 ml
EUR 286
Goat Anti-Mouse albumin IgG-FITC Conjugate
ALB11-FITC 100 ug
EUR 347
Goat Anti-Human albumin IgG-FITC Conjugate
ALBH13-FITC 100 ug
EUR 347
Recombinant (E.Coli) purified Protein G-FITC Conjugate
PRTG15-FITC 1 ml
EUR 202
Wheat germ agglutinin Lectin (WGA)-FITC conjugate
WGA15-FITC 0.5 ml
EUR 286
Goat Anti-Mouse IgG (Fc) IgG-FITC Conjugate
40151-FITC 1 ml
EUR 225
Monoclonal Anti-Adenovirus (many isotypes) IgG-FITC conjugate
ADV12-FITC 100 ul
EUR 469
Rabbit Anti-Luciferase (Photobacterium fischerii) IgG-FITC Conjugate
LUCF12-FITC 500 ul
EUR 384
Ricinus communis (castor bean) Agglutinin (RCA120)-FITC conjugate
RCA15-FITC 0.5 ml
EUR 225
Mouse Monoclonal Anti-Human IgG1 (Fc-region)-FITC conjugate
10121-FITC 0.5 ml
EUR 225
Mouse Monoclonal Anti-Human IgG2 (Fc-region)-FITC conjugate
10122-FITC 0.5 ml
EUR 225
Mouse Monoclonal Anti-Human IgG3 (Hinge-region)-FITC conjugate
10123-FITC 0.5 ml
EUR 286
Mouse Monoclonal Anti-Human IgG4 (Fc-region)-FITC conjugate
10124-FITC 0.5 ml
EUR 286
Goat Anti-Adenovirus type 2, hexon IgG-FITC conjugate
ADV11-FITC 0.5 ml
EUR 408
Rabbit anti-Beta-Galactosidase (E. Coli) IgG-FITC conjugate
BGAL12-FITC 100 ul
EUR 347
Goat Anti-Poliomyelitis Virus 1-3 IgG-FITC Conjugate
POLV13-FITC 0.5 ml
EUR 408
Goat Anti-Rubella virus (HPV77 strain) IgG-FITC conjugate
RUBL11-FITC 1 ml
EUR 347
Casein, FITC-conjugated
13440 5 mg
EUR 219
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200
FITC Conjugated Avidin
BA1125-0.5 0.5ml
EUR 187
FITC Conjugated Avidin
BA1125-1 1ml
EUR 334
Rabbit Anti-Bovine Serum Albumin (BSA) protein IgG-FITC Conjugate
ALBB14-FITC 0.5 ml
EUR 347
Goat Anti-Poly-His (6xhis) (His-tag) IgG-FITC conjugate
HISP16-FITC 100 ul
EUR 347
Goat Anti-Hemeagglutinin fusion epitope (HA-tag) IgG-FITC conjugate
HA12-FITC 100 ug
EUR 347
Goat Anti-Glutathione Transferase (GST, S. japonicum) IgG-FITC Conjugate
GST13-FITC 100 ul
EUR 347
Goat Anti-Human Respiratory Syncytial Virus (RSV) IgG-FITC conjugate
RSV12-FITC 0.5 ml
EUR 469
Monoclonal Anti-Human Beta Actin peptide (non-muscle) IgG-FITC Conjugate
ACTB12-FITC 100 ul
EUR 408
Mouse Monoclonal Anti-Actin (Pan, alpha, beta, gamma) IgG-FITC conjugate
ACTB24-FITC 100 ul
EUR 408
Goat Anti-human C-Reactive Protein (CRP)-FITC Conjugate, aff pure
CRP11-FITC 100 ug
EUR 408
Rabbit Anti-Vaccinia virus (VACV/VV/small pox) IgG-FITC conjugate
VACV11-FITC 0.5 ml
EUR 408
Goat Anti-Green Fluorescent Proteins (GFP, A. victoria) protein IgG-FITC conjugate
GFP11-FITC 100 ug
EUR 347
Monoclonal Anti-Green Fluorescent Proteins (GFP, A. victoria) protein IgG-FITC conjugate
GFP12-FITC 0.5 ml
EUR 408
F(ab')2 fragment, Goat Anti-Mouse IgG (Fab)2 IgG-FITC Conjugate
40155-FITC 0.5 ml
EUR 263
Mouse mono Anti-human CRP (C-Reactive Protein) (clone 1) IgG-FITC conjugate
CRP13-FITC 100 ug
EUR 347
Mouse monoclonal Anti-Rabies Virus IgG-FITC conjugate (DFA II mix of 2 clones)
RBV15-FITC 1 ml
EUR 286
CD7 antibody - FITC conjugated
61R-2068 1000 tests
EUR 435
Description: Monoclonal CD7 FITC Conjugated Antibody
PLIN4 Antibody, FITC conjugated
1-CSB-PA822286HC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against PLIN4. Recognizes PLIN4 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
TMEM237 Antibody, FITC conjugated
1-CSB-PA822287OC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ul
  • 50ul
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against TMEM237. Recognizes TMEM237 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
PSKH2 Antibody, FITC conjugated
1-CSB-PA822291LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against PSKH2. Recognizes PSKH2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
PASK Antibody, FITC conjugated
1-CSB-PA822296LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against PASK. Recognizes PASK from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
UCN2 Antibody, FITC conjugated
1-CSB-PA822298LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against UCN2. Recognizes UCN2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
CAMKK2 Antibody, FITC conjugated
1-CSB-PA822299LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against CAMKK2. Recognizes CAMKK2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
CXCL10 Antibody, FITC conjugated
1-CSB-PA822646LC01MOW
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against CXCL10. Recognizes CXCL10 from Macaca mulatta. This antibody is FITC conjugated. Tested in the following application: ELISA
LGI2 Antibody, FITC conjugated
1-CSB-PA822674LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against LGI2. Recognizes LGI2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
TTC5 Antibody, FITC conjugated
1-CSB-PA822676LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against TTC5. Recognizes TTC5 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
LSMEM2 Antibody, FITC conjugated
1-CSB-PA822677LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against LSMEM2. Recognizes LSMEM2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
CPXCR1 Antibody, FITC conjugated
1-CSB-PA822678LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against CPXCR1. Recognizes CPXCR1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
C4orf33 Antibody, FITC conjugated
1-CSB-PA822682LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against C4orf33. Recognizes C4orf33 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
NUP93 Antibody, FITC conjugated
1-CSB-PA822683LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against NUP93. Recognizes NUP93 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
BATF2 Antibody, FITC conjugated
1-CSB-PA822685LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against BATF2. Recognizes BATF2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
C20orf197 Antibody, FITC conjugated
1-CSB-PA822688DC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against C20orf197. Recognizes C20orf197 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
OSR2 Antibody, FITC conjugated
1-CSB-PA822691LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against OSR2. Recognizes OSR2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
PIAS4 Antibody, FITC conjugated
1-CSB-PA822692LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against PIAS4. Recognizes PIAS4 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
MUC20 Antibody, FITC conjugated
1-CSB-PA822693LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against MUC20. Recognizes MUC20 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
OR2L13 Antibody, FITC conjugated
1-CSB-PA822694LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against OR2L13. Recognizes OR2L13 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
PPM1K Antibody, FITC conjugated
1-CSB-PA822697LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against PPM1K. Recognizes PPM1K from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
GALNT15 Antibody, FITC conjugated
1-CSB-PA822698LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against GALNT15. Recognizes GALNT15 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
LIX1 Antibody, FITC conjugated
1-CSB-PA822702LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against LIX1. Recognizes LIX1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
STX19 Antibody, FITC conjugated
1-CSB-PA822703LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against STX19. Recognizes STX19 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
SPEM1 Antibody, FITC conjugated
1-CSB-PA822704LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against SPEM1. Recognizes SPEM1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
WDTC1 Antibody, FITC conjugated
1-CSB-PA822706LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against WDTC1. Recognizes WDTC1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
FAM160A2 Antibody, FITC conjugated
1-CSB-PA822711LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against FAM160A2. Recognizes FAM160A2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
RNF182 Antibody, FITC conjugated
1-CSB-PA822714LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against RNF182. Recognizes RNF182 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
IL22RA1 Antibody, FITC conjugated
1-CSB-PA822717LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against IL22RA1. Recognizes IL22RA1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
PCDH20 Antibody, FITC conjugated
1-CSB-PA822719LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against PCDH20. Recognizes PCDH20 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
EFHB Antibody, FITC conjugated
1-CSB-PA822723LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against EFHB. Recognizes EFHB from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
C2orf69 Antibody, FITC conjugated
1-CSB-PA822731LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against C2orf69. Recognizes C2orf69 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
C9orf163 Antibody, FITC conjugated
1-CSB-PA822739LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against C9orf163. Recognizes C9orf163 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
TRIML1 Antibody, FITC conjugated
1-CSB-PA822741LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against TRIML1. Recognizes TRIML1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
TERB1 Antibody, FITC conjugated
1-CSB-PA822742LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against TERB1. Recognizes TERB1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
C12orf50 Antibody, FITC conjugated
1-CSB-PA822743LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against C12orf50. Recognizes C12orf50 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
CASTOR3 Antibody, FITC conjugated
1-CSB-PA822746LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against CASTOR3. Recognizes CASTOR3 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
KDM1B Antibody, FITC conjugated
1-CSB-PA822748LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against KDM1B. Recognizes KDM1B from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
KLHL23 Antibody, FITC conjugated
1-CSB-PA822749LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against KLHL23. Recognizes KLHL23 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
UXS1 Antibody, FITC conjugated
1-CSB-PA822754LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against UXS1. Recognizes UXS1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
KCTD6 Antibody, FITC conjugated
1-CSB-PA822756LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against KCTD6. Recognizes KCTD6 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
SIMC1 Antibody, FITC conjugated
1-CSB-PA822768LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against SIMC1. Recognizes SIMC1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
NSUN7 Antibody, FITC conjugated
1-CSB-PA822769LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against NSUN7. Recognizes NSUN7 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
TRPV1 Antibody, FITC conjugated
1-CSB-PA822774LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against TRPV1. Recognizes TRPV1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
WFDC9 Antibody, FITC conjugated
1-CSB-PA822776LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against WFDC9. Recognizes WFDC9 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
ATP6V1C2 Antibody, FITC conjugated
1-CSB-PA822777LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against ATP6V1C2. Recognizes ATP6V1C2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
DBF4B Antibody, FITC conjugated
1-CSB-PA822784LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against DBF4B. Recognizes DBF4B from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
CDC26 Antibody, FITC conjugated
1-CSB-PA822822LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against CDC26. Recognizes CDC26 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
Nlrp3 Antibody, FITC conjugated
1-CSB-PA823181LC01MO
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against Nlrp3. Recognizes Nlrp3 from Mouse. This antibody is FITC conjugated. Tested in the following application: ELISA
P4HB Antibody, FITC conjugated
1-CSB-PA823188YC01DXU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against P4HB. Recognizes P4HB from Cricetulus griseus. This antibody is FITC conjugated. Tested in the following application: ELISA
CCDC26 Antibody, FITC conjugated
1-CSB-PA823440LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against CCDC26. Recognizes CCDC26 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
BBS10 Antibody, FITC conjugated
1-CSB-PA823443LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against BBS10. Recognizes BBS10 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
GSDMB Antibody, FITC conjugated
1-CSB-PA823445LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against GSDMB. Recognizes GSDMB from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
We organized the methods and options to handle the issues and points above into CPA framework (Clinotype Prediction and Association-finding). At the info preprocessing step, we dealt with the lacking worth problem with predicted accuracy of 0.760. We curated 12,635 clinotype-gene associations. We discovered 147 Associations between 147 continual diseases-phenotype and clinotypes, which improved the illness predictive efficiency to AUC (common) of 0.967. We mined 182 important clinotype-clinotype associations amongst 69 clinotypes.

An alternative food source for metabolism and longevity studies in Caenorhabditis elegans

An alternative food source for metabolism and longevity studies in Caenorhabditis elegans

Caenorhabditis elegans is an instrumental analysis mannequin used to advance our data in areas together with growth, metabolism, and getting old. However, analysis on metabolism and/or different measures of well being/getting old are confounded by the nematode’s food source in the lab, reside E. coli micro organism. Commonly used therapies, together with ultraviolet irradiation and antibiotics, are profitable in stopping bacterial replication, however the micro organism can stay metabolically energetic. The goal of this examine is to develop a metabolically inactive food source for the worms that may enable us to attenuate the confounding results of bacterial metabolism on worm metabolism and getting old.

Our technique is to make use of a paraformaldehyde (PFA) handled E. coli food source and to find out its results on worm well being, metabolism and longevity. We initially decide the bottom potential concentrations of PFA essential to quickly and reproducibly kill micro organism. We then measure numerous points of worm conduct, well beingspan and longevity, together with progress price, food attraction, brood measurement, lifespan and metabolic assessments, comparable to oxygen consumption and metabolomics. Our ensuing knowledge present that worms eat and develop effectively on these micro organism and assist the usage of 0.5% PFA-killed micro organism as a nematode food source for metabolic, drug, and longevity experiments.

Primary goal 1. To assess the consequences of offering grownup sufferers with entry to digital well being information (EHRs) alone or with extra functionalities on a variety of affected person, patient-provider, and well being useful resource consumption outcomes, together with affected person data and understanding, affected person empowerment, affected person adherence, affected person satisfaction with care, adversarial occasions, well being-related high quality of life, well being-related outcomes, psychosocial well being outcomes, well being useful resource consumption, and patient-provider communication. Secondary goal 1. To assess whether or not results of offering grownup sufferers with EHR entry alone versus EHR entry with extra functionalities differ amongst affected person teams in line with age, academic degree, or completely different standing of illness (power or acute).

An alternative food source for metabolism and longevity studies in Caenorhabditis elegans

Adult affected person entry to digital well being information

We included 10 studies with 78 to 4500 members and follow-up from three to 24 months. Nine studies assessed the consequences of EHR with extra functionalities, every addressing a subset of outcomes sought by this assessment. Five studies targeted on sufferers with diabetes mellitus, 4 on sufferers with particular ailments, and one on all sufferers. All studies in contrast EHR entry alone or with extra functionalities plus normal care versus normal care solely. No studies assessing the consequences of EHR entry alone versus EHR entry with extra functionalities had been recognized.

Interventions required a wide range of knowledge throughout the EHR, comparable to affected person historical past, drawback record, treatment, allergy symptoms, and lab outcomes. In addition to EHR entry, eight studies allowed sufferers to share self-documented knowledge, seven provided individualised illness administration features, seven provided academic disease-related info, six supported safe communication, and one provided preventive reminders. Only two studies had been at low or unclear threat of bias throughout domains. Meta-analysis couldn’t be carried out, as members, interventions, and outcomes had been too heterogeneous, and most studies introduced outcomes primarily based on completely different adjustment strategies or variables.

The high quality of proof was rated as low or very low throughout outcomes. Overall variations between intervention and management teams, if any, had been small. The relevance of any small results stays unclear for most outcomes as a result of in most instances, trial authors didn’t outline a minimal clinically essential distinction. Overall, outcomes recommend that the consequences of EHR entry alone and with extra functionalities are principally unsure compared with normal care. Patient data and understanding: very low-quality proof is offered from one examine, so we’re unsure about results of the intervention on affected person data about diabetes and blood glucose testing.

Patient empowerment: low-quality proof from three studies means that the intervention might have little or no impact on affected person empowerment measures. Patient adherence: low-quality proof from two studies means that the intervention might barely enhance adherence to the method of monitoring threat components and preventive providers. Effects on treatment adherence are conflicting in two studies; this will likely or might not enhance to a clinically related diploma. Patient satisfaction with care: low-quality proof from three studies means that the intervention might have little or no impact on affected person satisfaction, with conflicting outcomes.

Anti-RXR-γ Antibody

A04250-1 1ml
EUR 464
Description: Rabbit Polyclonal RXR-γ Antibody. Validated in IHC and tested in Human, Mouse, Rat.

Anti-Interferon gamma Antibody

A00393-1 100ug/vial
EUR 294

Rabbit Polyclonal antibody Anti-CRBN

Anti-CRBN 50 µg
EUR 349

Recombinant Rat MIP-1 Alpha (CCL3) Protein

PROTP50229-1 20ug
EUR 317
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant rat MIP-1α is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Recombinant Rat MIP-1 Beta (CCL4) Protein

PROTP50230-1 20ug
EUR 317
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant rat MIP-1β is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Recombinant Murine MIP-1 Beta (CCL4) Protein

PROTP14097-1 10ug
EUR 317
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant murine MIP-1β is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Anti-MIP-1 alpha Antibody

A00405 100ug
EUR 432
Description: Rabbit Polyclonal MIP-1 alpha Antibody. Validated in WB and tested in Mouse.

MIP-1 Macrophage Inflammatory Protein-1 Gamma Mouse Recombinant Protein (CCL9)

PROTP51670 Regular: 20ug
EUR 317
Description: MIP-1 gamma Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 101 amino acids and having a molecular mass of 11.6 kDa. The MIP-1 gamma is purified by proprietary chromatographic techniques.

Mouse CCL9/Mip 1 Gamma PicoKine™ Fast ELISA Kit

FEK1225 96 wells
EUR 475
Description: The Fast version of Picokine ELISA kits, assay takes less than 1.5 hours. Detect Mouse Mip 1 Gamma/Ccl9 with <1pg/ml sensitivity. Format: 96-well plate with removable strips. Compatible samples: cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). This is a TMB colorimetric sandwich ELISA kit with short assay time and fast experiment set up. Mip 1 Gamma/Ccl9 tissue specificity: Expressed mainly in the liver, lung, and the thymus, although some expression has been The Fast version of Picokine ELISA kits, assay takes less than 1.5 hours. Detected in a wide variety of tissues except brain.

Anti-CEBPG/Cebp Gamma Antibody

A09205-1 100ul
EUR 397
Description: Rabbit Polyclonal CEBPG/Cebp Gamma Antibody. Validated in IHC, WB and tested in Human, Mouse, Rat.

Anti-NEMO/IKK-gamma Antibody

A00874-1 100ug
EUR 455
Description: Rabbit Polyclonal NEMO/IKK-gamma Antibody. Validated in IP, WB and tested in Human.

Anti-PAK gamma Monoclonal Antibody

A01419-1 100ul
EUR 397
Description: Mouse Monoclonal Antibody for PAK gamma Antibody (PAK2) detection. Tested with WB, IHC, IF in Human, Monkey.

Anti-gamma Catenin/JUP Antibody

PA1117-1 100ug/vial
EUR 294

Anti-IKK gamma/IKBKG Antibody

PA1551-1 100ug/vial
EUR 294

Anti-HP1 gamma Monoclonal Antibody

M01142-1 100ug
EUR 397
Description: Rabbit Monoclonal HP1 gamma Antibody. Validated in IP, WB and tested in Human, Mouse, Rat.

MIP-1a Macrophage Inflammatory Protein-1 Alpha Mouse Recombinant Protein (CCL3)

PROTP10855-1 Regular: 10ug
EUR 317
Description: Macrophage Inflammatory Protein-1 alpha Mouse Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 69 amino acids and having a molecular mass of 7820 Dalton. ;The MIP-1a is purified by proprietary chromatographic techniques.

anti- MIP antibody

FNab05193 100µg
EUR 548.75
  • Recommended dilution: WB: 1:500 - 1:1000
  • IHC: 1:100 - 1:200
  • Immunogen: major intrinsic protein of lens fiber
  • Uniprot ID: P30301
  • Gene ID: 4284
  • Research Area: Neuroscience
Description: Antibody raised against MIP

anti- MIP-3

LSMab09791 100 ug
EUR 386

Anti-MIP antibody

PAab05193 100 ug
EUR 386

Anti-MIP antibody

STJ24556 100 µl
EUR 277
Description: Major intrinsic protein is a member of the water-transporting aquaporins as well as the original member of the MIP family of channel proteins. The function of the fiber cell membrane protein encoded by this gene is undetermined, yet this protein is speculated to play a role in intracellular communication. The MIP protein is expressed in the ocular lens and is required for correct lens function. This gene has been mapped among aquaporins AQP2, AQP5, and AQP6, in a potential gene cluster at 12q13.

MIP-1

EF000186 96 Tests
EUR 689

MIP-1

EF016834 96 Tests
EUR 689

MIP-1

EF017045 96 Tests
EUR 689

MIP-1

EF017887 96 Tests
EUR 689

MIP-1

EF013758 96 Tests
EUR 689

MIP-1

EF013759 96 Tests
EUR 689

MIP-1

EF016651 96 Tests
EUR 689

MIP-1

EF012725 96 Tests
EUR 689

Rabbit Anti Mouse Mip-1 Alpha Polyclonal Antibody

CPBT-65209RM 0.1 mg
EUR 881

Anti-Fibrinogen gamma chain/FGG Antibody

A00790-1 100ug/vial
EUR 334

Anti-Interferon gamma Rabbit Monoclonal Antibody

M00393-1 100ug/vial
EUR 397
Description: Rabbit Monoclonal Interferon gamma Antibody. Validated in Flow Cytometry, IF, ICC, WB and tested in Human, Mouse, Rat.

Anti-Catenin gamma Rabbit Monoclonal Antibody

M01901-1 100ug/vial
EUR 397
Description: Rabbit Monoclonal Catenin gamma Antibody. Validated in IF, WB and tested in Human, Mouse, Rat.

Mouse Interferon-gamma (IFN-gamma) AssayMax ELISA Kit

EMI1023-1 96 Well Plate
EUR 477

MIP-3beta, murine recombinant protein

P1049-.1 100 µg
EUR 877
Description: Macrophage inflammatory protein-3 ? (MIP-3?) is a CC chemokine produced in the thymus, lymph nodes and activated bone marrow stromal cells. MIP-3? signals through the chemokine receptor CCR-7/EBI-1/BLR-2. MIP-3? is a chemoattractant for T and B lymphocytes, and myeloid progenitor cells.

MIP-3beta, murine recombinant protein

P1049-1 1 mg
EUR 5548
Description: Macrophage inflammatory protein-3 ? (MIP-3?) is a CC chemokine produced in the thymus, lymph nodes and activated bone marrow stromal cells. MIP-3? signals through the chemokine receptor CCR-7/EBI-1/BLR-2. MIP-3? is a chemoattractant for T and B lymphocytes, and myeloid progenitor cells.

Anti-Interferon gamma Biotinylated Antibody

A00393-1-Biotin 50ug/vial
EUR 294

Anti-strogen Related Receptor gamma/ESRRG Antibody

A01470-1 100ug/vial
EUR 334

Anti-MIP-5 Antibody

A05563 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for MIP-5 Antibody (CCL15) detection.tested for IHC in Human.

Anti-MIP-1b Antibody

A16621 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for MIP-1b Antibody (CCL4L1) detection. Tested with WB in Human.

anti- MIP-3α antibody

FNab09791 100µg
EUR 548.75
  • Recommended dilution: IHC: 1:50-1:500
  • Immunogen: chemokine(C-C motif) ligand 20
  • Uniprot ID: P78556
  • Research Area: Immunology, Signal Transduction
Description: Antibody raised against MIP-3α

Anti-MIP- alpha antibody

STJ94130 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-1alpha.

Anti-MIP- beta antibody

STJ94131 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-3beta.

Anti-MIP-T3 antibody

STJ94133 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-T3.

Anti-MIP- beta antibody

STJ96572 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-1beta.

Anti-MIP-1b antibody

STJ97347 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-1b.

Anti-MIP- alpha antibody

STJ98775 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-3alpha.

Anti-MIP-5 antibody

STJ98780 200 µl
EUR 197
Description: Rabbit polyclonal to MIP-5.

Recombinant Human MIP-3 (CCL23) Protein

PROTP55773-1 20ug
EUR 317
Description: MIP-3 is a CC chemokine that signals through the CCR1 receptor. MIP-3 chemoattracts monocytes, resting T-lymphocytes and neutrophils, but does not chemoattract activated lymphocytes. Additionally, MIP-3 has been shown to inhibit colony formation of bone marrow myeloid immature progenitors. Recombinant human MIP-3 is an 11.3 kDa protein containing 99 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Recombinant Murine MIP-2 (CXCL2) Protein

PROTP10889-1 20ug
EUR 317
Description: All three isoforms of GRO are CXC chemokines that can signal through the CXCR1 or CXCR2 receptors. The GRO proteins chemoattract and activate neutrophils and basophils. Recombinant murine MIP-2 is a 7.8 kDa protein consisting of 73 amino acids including the 'ELR' motif common to the CXC chemokine family that bind to CXCR1 or CXCR2.

anti-AMPK gamma 1

YF-PA13985 100 ug
EUR 403
Description: Rabbit polyclonal to AMPK gamma 1

anti-Laminin gamma 1

YF-PA24068 50 ul
EUR 334
Description: Mouse polyclonal to Laminin gamma 1

Recombinant Human MIP-3 Beta (CCL19) Protein

PROTQ99731-1 20ug
EUR 317
Description: MIP-3β is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3β is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3β is active on murine cells. Recombinant human MIP-3β is an 8.8 kDa protein containing 77 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Recombinant Murine MIP-3 Alpha (CCL20) Protein

PROTO89093-1 20ug
EUR 317
Description: MIP-3α is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and signals through the CCR6 receptor. MIP-3α is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Recombinant murine MIP-3α is a 7.9 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Rabbit Anti Mouse Mip-2 Polyclonal Antibody

CPBT-65215RM 0.1 mg
EUR 881

Polyclonal Goat anti-GST μ-form

GST-ANTI-2 50 uL
EUR 280

Polyclonal Goat anti-GST p-form

GST-ANTI-3 50 uL
EUR 280

MIP-1 beta, CCL4, murine (mouse)

RC335-15 2ug
EUR 104.38
  • Product category: Proteins/Recombinant Proteins/Cytokines

Anti-MIP-3 alpha Antibody

A00748 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for MIP-3 alpha Antibody (CCL20) detection.tested for IHC in Human, Mouse.

anti- MIP-3-beta antibody

FNab05194 100µg
EUR 505.25
  • Immunogen: chemokine(C-C motif) ligand 19
  • Uniprot ID: Q99731
  • Research Area: Immunology, Signal Transduction
Description: Antibody raised against MIP-3-beta

Anti-Aquaporin 0/MIP Antibody

PA2110 100ug/vial
EUR 294

Anti-MIP-3-beta antibody

PAab05194 100 ug
EUR 355

Anti-Aquaporin 0/MIP Antibody

PB9811 100ug/vial
EUR 294

Anti-CXCL2 / MIP-2 antibody

STJ71916 100 µg
EUR 359

Rabbit Anti-Mouse Synuclein-gamma antiserum # 1

SYN14-S 100 ul
EUR 457

Recombinant Rat GRO-Beta /MIP-2 (CXCL2) Protein

PROTP30348-1 25ug
EUR 317
Description: All three isoforms of GRO are CXC chemokines that can signal through the CXCR1 or CXCR2 receptors. The GRO proteins chemoattract and activate neutrophils and basophils. Recombinant rat GRO-β/MIP-2 is a 7.9 kDa protein consisting of 73 amino acids including the 'ELR' motif common to the CXC chemokine family that bind to CXCR1 or CXCR2.

Goat Anti Human Mip-1 Alpha Polyclonal Antibody

CPBT-65207GH 0.1 mg
EUR 881

Rabbit Anti Rat Mip-1 Alpha Polyclonal Antibody

CPBT-65211RR 0.1 mg
EUR 881

Rabbit Anti Human Mip-1 Beta Polyclonal Antibody

CPBT-65212RH 0.1 mg
EUR 881

MIP-1a Macrophage Inflammatory Protein-1 Alpha Human Recombinant Protein (CCL3), His Tag

PROTP10147-1 Regular: 10ug
EUR 317
Description: Macrophage Inflammatory Protein-1 alpha His Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 68 amino acids and having a molecular mass of 7820 Dalton with an amino-terminal hexahistidine tag. ;The MIP-1a-His is purified by proprietary chromatographic techniques.

Human Interferon-gamma (IFN-gamma) AssayMax ELISA Kit

EI1023-1